Sage Therapeutics
SAGE
$11.90
Share price
-3.57%
Change (1 day)
-77.37%
Change (1 year)
Categories
Sage Therapeutics (SAGE) - Cash on Hand
Cash on Hand as of March 2024 : $0.71 B
According to Sage Therapeutics
's latest financial reports the company has $0.71 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Sage Therapeutics - Cash on Hand chart (from 2013 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.75 B | -40.81% |
| 2022-12-31 | $1.27 B | -26.96% |
| 2021-12-31 | $1.74 B | -17.02% |
| 2020-12-31 | $2.09 B | 108.21% |
| 2019-12-31 | $1.00 B | 9.28% |
| 2018-12-31 | $0.92 B | 77.85% |
| 2017-12-31 | $0.51 B | 30.53% |
| 2016-12-31 | $0.39 B | 112.84% |
| 2015-12-31 | $0.18 B | 46.17% |
| 2014-12-31 | $0.12 B | 1484.01% |
| 2013-12-31 | $8.06 M | 187.87% |
| 2012-12-31 | $2.8 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Regulus Therapeutics RGLS | $23.76 M | -96.69% | 🇺🇸 USA |
 Intercept Pharmaceuticals
ICPT | $0.32 B | -54.99% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | $2.46 B | 243.73% | 🇮🇪 Ireland |
 Eagle Pharmaceuticals
EGRX | $15.35 M | -97.86% | 🇺🇸 USA |